These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 4403139)

  • 1. Dopamine: mediator of brain polysome disaggregation after L-dopa.
    Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
    Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatic amino acid decarboxylase inhibitors.
    Porter CC
    Fed Proc; 1971; 30(3):871-6. PubMed ID: 5575298
    [No Abstract]   [Full Text] [Related]  

  • 3. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1971 Mar; 6(3):215-7. PubMed ID: 5125476
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 6. Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase.
    Bartholini G; Constantinidis J; Tissot R; Pletscher A
    Biochem Pharmacol; 1971 Jun; 20(6):1243-7. PubMed ID: 5315769
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
    Weiss BF; Roel LE; Munro HN; Wurtman RJ
    Adv Neurol; 1974; 5():87-99. PubMed ID: 4155238
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.
    Uretsky NJ; Seiden LS
    J Pharmacol Exp Ther; 1969 Jul; 168(1):153-62. PubMed ID: 4307318
    [No Abstract]   [Full Text] [Related]  

  • 9. L-dopa: disaggregation of brain polysomes and elevation of brain tryptophan.
    Weiss BF; Munro HN; Wurtman RJ
    Science; 1971 Aug; 173(3999):833-5. PubMed ID: 5572175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR; Messiha FS; Hsu TH
    Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
    [No Abstract]   [Full Text] [Related]  

  • 11. Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.
    Constantinidis J; Gaillard JM; Geissbuhler F; Tissot R
    Br J Pharmacol; 1971 Sep; 43(1):32-8. PubMed ID: 5136462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the cardiovascular effects of L-dopa in anesthetized dogs by inhibitors of enzymes involved in catecholamine metabolism.
    Robson RD
    Circ Res; 1971 Jun; 28(6):662-70. PubMed ID: 4325846
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
    Seiden LS; Martin TW
    Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
    [No Abstract]   [Full Text] [Related]  

  • 15. Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent.
    Goldstein M; Battista AF; Ohmoto T; Anagnoste B; Fuxe K
    Science; 1973 Feb; 179(4075):816-7. PubMed ID: 4630708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the localization of the hypotensive effect of L-dopa.
    Henning M; Rubenson A; Trolin G
    J Pharm Pharmacol; 1972 Jun; 24(6):447-51. PubMed ID: 4403826
    [No Abstract]   [Full Text] [Related]  

  • 17. Further studies on the mechanism of the central hypotensive effect of L-dopa, DL-m-tyrosine and L-alpha-methyldopa.
    Rubenson A
    J Pharm Pharmacol; 1971 Mar; 23(3):228-30. PubMed ID: 4396899
    [No Abstract]   [Full Text] [Related]  

  • 18. Histamine formation in rat brain in vivo: effects of histidine loads.
    Schwartz JC; Lampart C; Rose C
    J Neurochem; 1972 Mar; 19(3):801-10. PubMed ID: 5030985
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of peripheral aromatic L-amino acids decarboxylase inhibitor on L-(2- 14 C)-3,4-dihydroxyphenylalanine metabolism in man.
    Messiha FS; Hsu TH; Bianchine JR
    Biochem Pharmacol; 1972 Aug; 21(15):2144-7. PubMed ID: 4645885
    [No Abstract]   [Full Text] [Related]  

  • 20. Block of cerebral actions of L-dopa with methyl receptor substances.
    Cotzias GC; Tang L; Ginos JZ; Nicholson AR; Papavasiliou PS
    Nature; 1971 Jun; 231(5304):533-5. PubMed ID: 4934569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.